IHS Chemical Week

Bayer to acquire birth control firm Conceptus for $1.1 billion

11:48 AM MDT | April 29, 2013

Bayer HealthCare has signed a merger agreement with Conceptus (Mountain View; CA), the developer of the Essure procedure—a leading nonsurgical, permanent birth-control method, Bayer announced today. Bayer, following the acquisition, will be able to offer a complete range of short-term, long-term, and permanent contraceptive choices for women, the company says. Bayer will launch a public tender offer to acquire all shares in Conceptus within the next 10 business days in a transaction valuing Conceptus at approximately $1.1 billion, representing $31.00/share in...

Access is for Chemweek 24/7 PLUS Members ONLY

This information is only available to Chemweek 24/7 PLUS members who have subscribed to Chemweek’s Business Daily. If you are a member, please log in, OR if you have a trial membership, please use your trial membership account information. 


Forgot your user ID or password? Click here to have it sent to you.

contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa